Physician profile
Susan E Janocik
NPI 1225101504
$2,037.50
in general payments reported to CMS, 2019-2025
24 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $150 · 2024: $248 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $492.72 | 2019-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $311.32 | 2019-2025 | Farxiga |
| Novo Nordisk INC | $205.39 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $126.63 | 2019-2020 | |
| Amarin Pharma, INC. | $119.67 | 2019 | |
| Lilly USA, LLC | $117.34 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $96.05 | 2019-2025 | |
| Abbvie INC. | $79.81 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $70.67 | 2019 | |
| Exact Sciences Corporation | $62.35 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $55.34 | 2019-2020 | |
| Pfizer INC. | $49.85 | 2019 | |
| Phathom Pharmaceuticals, INC. | $40.51 | 2025 | Voquezna |
| Eisai INC. | $35.86 | 2019 | |
| Vivus LLC | $30.02 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $29.13 | 2019-2020 | |
| Radius Health, INC. | $23.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.84 | 2025 | Jardiance |
| Allergan, INC. | $13.29 | 2019 | |
| Genentech USA, INC. | $12.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.39 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.94 | 2019 | |
| Promius Pharma LLC | $11.89 | 2019 | |
| Sanofi Pasteur INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Janocik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.